相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。microRNAstrand selection: Unwinding the rules
Jeffrey C. Medley et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Molecular Mechanisms of Bortezomib Action: Novel Evidence for the miRNA-mRNA Interaction Involvement
Karolina Luczkowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
MicroRNA-33b regulates hepatocellular carcinoma cell proliferation, apoptosis, and mobility via targeting Fli-1-mediated Notch1 pathway
Huiling Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
A Mechanism for microRNA Arm Switching Regulated by Uridylation
Haedong Kim et al.
MOLECULAR CELL (2020)
Up-regulated cytotrophoblast DOCK4 contributes to over-invasion in placenta accreta spectrum
Leah McNally et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer
Albert Jang et al.
CANCERS (2020)
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
Rachel Sexton et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
microRNA arm-imbalance in part from complementary targets mediated decay promotes gastric cancer progression
Zhengyi Zhang et al.
NATURE COMMUNICATIONS (2019)
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer
Jules A. Westbrook et al.
JOURNAL OF PATHOLOGY (2019)
CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression
Mingfeng Zhao et al.
PROSTATE (2019)
A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder
Teruo Inamoto et al.
DISEASE MARKERS (2018)
Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP
Hui Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
MicroRNAs and metastasis: small RNAs play big roles
Jongchan Kim et al.
CANCER AND METASTASIS REVIEWS (2018)
Proteasome inhibitors in cancer therapy
Elisabet E. Manasanch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells
Yuran Gao et al.
CELL DEATH & DISEASE (2017)
Prognostic role of circulating exosomal miRNAs in multiple myeloma
Salomon Manier et al.
BLOOD (2017)
DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21(WAF1/CIP1)
Shun Xu et al.
CELL CYCLE (2016)
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1
Yuan Wang et al.
MOLECULAR CANCER (2016)
TGF-β/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis
Jia-Ray Yu et al.
GENES & DEVELOPMENT (2015)
Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma
Fei Li et al.
LEUKEMIA RESEARCH (2015)
Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection
Jun Tao et al.
MOLECULAR MEDICINE REPORTS (2015)
miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
Nahyun Choi et al.
ONCOTARGET (2015)
Evolutionary and Expression Analysis of miR-#-5p and miR-#-3p at the miRNAs/isomiRs Levels
Li Guo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma
Mu Hao et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells
Jianquan Guo et al.
PLOS ONE (2015)
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Matjaz Rokavec et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression
Lekun Fang et al.
ONCOTARGET (2014)
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells
Ze Tian et al.
BLOOD (2012)
New Perspectives in the Therapy of Castration Resistant Prostate Cancer
Pasquale Rescigno et al.
CURRENT DRUG TARGETS (2012)
Castration-Resistant Prostate Cancer Current and Emerging Treatment Strategies
Giuseppe Di Lorenzo et al.
DRUGS (2010)
MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression.
Yasunori Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading
Douglas R. Hurst et al.
CANCER RESEARCH (2009)
Linking metastasis suppression with metastamiR regulation
Mick D. Edmonds et al.
CELL CYCLE (2009)
Clinical development of novel proteasome inhibitors for cancer treatment
Huanjie Yang et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Weekly docetaxel and bortezomib as first-line treatment for patients with hormone-refractory prostate cancer: A minnie pearl cancer research network phase II trial
John D. Hainsworth et al.
CLINICAL GENITOURINARY CANCER (2007)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
DOCK4, a GTPase activator, is disrupted during tumorigenesis
V Yajnik et al.
CELL (2003)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
分享论文
